Virtual Reality Pediatric Orthopaedic Outpatient Procedures
VPRO
Virtual Reality in Reducing Pain and Anxiety in Pediatric Orthopaedics, a Pilot Randomized Controlled Trial
1 other identifier
interventional
110
1 country
1
Brief Summary
The main objective of the study is to evaluate the use of Virtual Reality (VR) in managing pain and anxiety levels during common pediatric orthopaedic outpatient procedures which include: cast application, cast removal, hardware removal (ie. pins and screws), and botox injections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Feb 2019
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2018
CompletedFirst Posted
Study publicly available on registry
December 21, 2018
CompletedStudy Start
First participant enrolled
February 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2019
CompletedMarch 2, 2020
February 1, 2020
3 months
December 13, 2018
February 27, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Wong Baker Scale (WBS) for Procedural Pain
The WBS is a self-reported outcome measure that asks patients to rate their pain severity by circling the face that best describes the pain on a horizontally positioned VAS with marked end points of "no pain" and "worst possible pain". There are six possible faces with "no pain" representing a score of 0 and "worst pain" representing a score of 10
Immediately post procedure
Anxiety (state anxiety intraprocedure)
Intraprocedural state anxiety will be measured using the The Children's Emotional Manifestation Scale (CEMS) which consists of five categories that include: Facial expression, vocalization, activity, interaction and level of cooperation. A score is obtained by reviewing five descriptions in each category and selecting the number that most clearly represents the observed behavior. Each category is given a score from 1 to 5 for a total score of 5-25. A higher score corresponds to a more distressed child.
Intraprocedure
Secondary Outcomes (5)
Procedural Time
Intraprocedure
Baxter Retching Faces (BARF) Scale for Nausea
Immediately post procedure
State Anxiety Preprocedure
Immediately pre-procedure
State Anxiety Postprocedure
Immediately post procedure
Trait Anxiety
Preprocedure while in the waiting area
Study Arms (2)
Virtual Reality (VR)
EXPERIMENTALThe intervention will consist of standard of care (SOC) in addition to the use of virtual reality. SOC consists of the technician/care provider explaining the procedure while using speech to be comforting and supportive in addition to parent/guardians being allowed to console and distract their child during the procedure and interacting with other distractions techniques that may be available (ie. ipad, or mobile device) Patients assigned to the VR group will interact with VR through mobile-based VR googles.
No Virtual Reality (VR)
NO INTERVENTIONThis arm will receive regular standard of care (SOC), the same that would be received if they were not enrolled in the study. SOC will include the technician/care provider explaining the procedure while using speech to be comforting and supportive in addition to parent/guardians being allowed to console and distract their child during the procedure and interacting with other distractions techniques that may be available (ie. ipad, or mobile device)
Interventions
Eligibility Criteria
You may qualify if:
- child must be between the ages of 4 and 18 years
- the parent/guardians and child are both able to speak and read English or have a translator be present for them
You may not qualify if:
- symptoms of respiratory or gastrointestinal infection
- visual, auditory, cognitive impairment or developmental delay
- history of seizures or epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
British Columbia Children's Hospital
Vancouver, Ontario, V6H3N1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kishore Mulpuri, MBBS
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Student
Study Record Dates
First Submitted
December 13, 2018
First Posted
December 21, 2018
Study Start
February 5, 2019
Primary Completion
May 10, 2019
Study Completion
May 17, 2019
Last Updated
March 2, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share